Sterling Capital Management »

Vor Biopharma shares owned by Sterling Capital Management

Quarter-by-quarter ownership of Vor Biopharma (VOR) shares owned by Sterling Capital Management from 13F filings

Historical chart of Sterling Capital Management investment in Vor Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Vor Biopharma held by Sterling Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vor Biopharma by Sterling Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $6.5k 355 18.41

More positions owned by Sterling Capital Management

Rreef Core Plus Residential Fu LP
Vanguard S&p 500 Etf Etf (VOO)
NVIDIA Corporation (NVDA)
Manulife Co-investment Partner LP
Microsoft Corporation (MSFT)
Apple (AAPL)
Tq Db Pension Priv Inv Adm LP
Alphabet Inc Class A cs (GOOGL)
Alphabet Inc Class C cs (GOOG)
JPMorgan Chase & Co. (JPM)
Charles Schwab Corporation (SCHW)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Amazon (AMZN)
Analog Devices (ADI)

View all positions for Sterling Capital Management

Top funds holding Vor Biopharma

TCG Crossover Management
FMR
Fcpm Iii Services B.v.
BlackRock
VR Adviser
Frazier Life Sciences Management
RA Capital Management
Vanguard Capital Management
Caligan Partners
Paradigm Biocapital Advisors
Dr. Jeffrey R. Jay, M.D.
State Street Corporation
Geode Capital Management
Nantahala Capital Management
ADAR1 Capital Management

View all funds holding Vor Biopharma